Clinical trials recruiting for BRCA2 Mutation
10
Recruiting trials
13
US states with sites
6
Countries
10%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Olaparib | 3 |
| Axatilimab | 1 |
| BCNU | 1 |
| Carboplatin | 1 |
| ETX-19477 | 1 |
| MRCP | 1 |
| Melphalan | 1 |
| Olaparib + Elacestrant | 1 |
| Paclitaxel | 1 |
| Pembrolizumab | 1 |
| Vitamin B12B | 1 |
| Vitamin C | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 4 |
| New York | 2 |
| Arizona | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Illinois | 1 |
| Minnesota | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
| Utah | 1 |
| Virginia | 1 |
Top cities
Boston, Massachusetts 4New York, New York 2Chicago, Illinois 1Columbus, Ohio 1Fairfax, Virginia 1Houston, Texas 1Jacksonville, Florida 1New Haven, Connecticut 1Philadelphia, Pennsylvania 1Phoenix, Arizona 1
Self-screener
Recruiting trials
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
- Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2
- Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
- Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
- Prostate Cancer Genetic Risk Evaluation and Screening Study
- Registry of Subjects at Risk of Pancreatic Cancer
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
Related conditions
Trials recruiting for BRCA2 Mutation often also study these conditions. Each links to its own recruiting-trial list.
BRCA1 Mutation 8Breast cancer 2239Colorectal cancer 1359Lynch Syndrome 28Prostate cancer 1234Pancreatic cancer 870Ovarian cancer 118Melanoma 487HER2-negative Breast Cancer 57BRCA Mutation 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for BRCA2 Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.